Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia.
作者信息
Herman S E M, Barr P M, McAuley E M, Liu D, Wiestner A, Friedberg J W
出版信息
Leukemia. 2013 Aug;27(8):1769-73. doi: 10.1038/leu.2013.37. Epub 2013 Feb 6.
Abstract
摘要
Zotero 插件